What makes a temperate phage an effective bacterial weapon? (2024)

First Author: Thomas M
Attributed to:  Does CRISPR-Cas immunity limit the effectiveness of phage therapy? funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1128/msystems.01036-23

Publication URI: http://dx.doi.org/10.1128/msystems.01036-23

Type: Journal Article/Review

Parent Publication: mSystems